OTC Healthcare - Japan
OTC Healthcare in Japan : Market Insight
EXECUTIVE SUMMARY
Ongoing growth due to demographic and lifestyle change Self-medication brings both opportunity and threat Changes in tax and sales network Shift towards nuclear family creates innovative packaging Acquisiton is key to future growth Vitamins and dietary supplements to dominate projected sales KEY TRENDS AND DEVELOPMENTS
Demographic change creates demand for anti-ageing products Legislation eases regulations on OTC sales Self-medication to prevent illness needs marketing Increased merger and acquisition activity in manufacturers and retailers Increasing number of nuclear families and single-person households exerts a growing influence MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC registration and classification Vitamins and dietary supplements registration and classification Generics Consumer expenditure on health goods and medical services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Local Company Profiles - Japan
Eisai Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 1 Eisai Co Ltd: Key Facts
Summary 2 Eisai Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 3 Eisai Co Ltd: Competitive Position 2006
Hisamitsu Pharmaceutical Co Inc - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2006
Lion Corp - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 7 Lion Corp: Key Facts
Summary 8 Lion Corp: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 9 Lion Corp: Competitive Position 2006
Miki Corp - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 10 Miki Corp: Key Facts
Summary 11 Miki Corp: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 12 Miki Corp: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 13 Miki Corp: Competitive Position 2006
Rohto Pharmaceutical Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 14 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 15 Rohto Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 16 Rohto Pharmaceutical Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 17 Rohto Pharmaceutical Co Ltd: Competitive Position 2006
Sankyo Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 18 Sankyo Co Ltd: Key Facts
Summary 19 Sankyo Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 20 Sankyo Co Ltd: Competitive Position 2006
Sato Pharmaceutical Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 21 Sato Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND PRODUCTION
Summary 22 Sato Pharmaceutical Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 23 Sato Pharmaceutical Co Ltd: Competitive Position 2006
SSP Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 24 SSP Co Ltd: Key Facts
Summary 25 SSP Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 26 SSP Co Ltd: Competitive Position 2006
Taisho Pharmaceutical Co Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 27 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 28 Taisho Pharmaceutical Co Ltd]: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 29 Taisho Pharmaceutical Co Ltd: Competitive Position 2006
Takeda Chemical Industries Ltd - OTC Healthcare - Japan
STRATEGIC DIRECTION KEY FACTS
Summary 30 Takeda Chemical Industries Ltd: Key Facts
Summary 31 Takeda Chemical Industries Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 32 Takeda Chemical Industries Ltd: Competitive Position 2006
Medicated skin care in Japan
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Medicated Skin Care 2001/2006
Table 15 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 16 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 17 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 18 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
